Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells

Journal of Immunology

Volumn 152, Issue 12, 1994, Pages 5624-5632

  Daniel, Peter T ^a,b   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Section of Pathology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G3; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; ANTIGENS, CD95; ANTIGENS, SURFACE; APOPTOSIS; B-LYMPHOCYTES; DIPHTHERIA TOXOID; DNA, SINGLE-STRANDED; HUMANS; IMMUNE TOLERANCE; IMMUNIZATION; LYMPHOCYTE ACTIVATION; MICE; MICE, SCID; POKEWEED MITOGENS; TETANUS TOXOID;

EID: 0028238410     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Duke, R. C., R. Chervenak, and J. J. Cohen. 1983. Enogenous endonuclease-induced DNA-fragmentation: an early event in cell-mediated cytolysis. Proc. Natl. Acad. Sci. USA 80:6361.
2. Cohen, J. J., and R. C. Duke. 1984. Glucocorticoid activation of a calcium dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132:38.
3. Goodnow, C. C. 1989. Cellular mechanisms of self-tolerance. Curr. Opin. Immunol. 2:226.
4. Nemazee, D. A., and K. Bürki. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337:562.
5. Murakami, M., T. Tsubata, M. Okamoto, A. Shimizu, S. Kumagai, H. Imura, and T. Honjo. 1992. Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature 357:77.
6. Liu, Y. J., D. E. Joshua, G. T. Williams, C. A. Smith, J. Gordon, and I. C. MacLennan. 1989. Mechanism of antigen-driven selection in germinal centres. Nature 342:929.
7. Trauth, B. C., C. Klas, A. M. Peters, S. Matzku, P. Möller, W. Falk, K. M. Debatin, and P. H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
8. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
9. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B. C. Trauth, H. Ponstingl, and P. H. Krammer. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the TNF/NGF receptor superfamily. J. Biol. Chem. 267:10709.
10. Dhein, J., P. T. Daniel, B. C. Trauth, A. Oehm, P. Möller, and P. H. Krammer. 1992. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149:3166.
11. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
12. Watanabe-Fukunuga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
13. Reap, E. A., E. S. Sobel, P. L. Cohen, and R. A. Eisenberg. 1993. Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice. J. Exp. Med. 177:69.
14. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
15. Sobel, E. S., T. Katagiri, K. Katagiri, S. C. Morris, P. L. Cohen, and R. A. Eisenberg. 1991. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J. Exp. Med. 172:1441.
16. Cohen, P. L., and R. A. Eisenberg. 1992. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol. Today 13:427.
17. Owen-Schaub, L., S. Yonehara, W. L. Crump, and E. A. Grimm. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140:197.
18. Klas, C., K.-M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625.
19. Keightley, R., M. Cooper, and A. Lawton. 1976. The T cell dependence of B cell differentiation induced by pokeweed mitogen. J. Immunol. 117:1538.
20. Mosier, D. E., R. J. Gulizia, S. M. Baird, and D. B. Wilson. 1988. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256.
21. Behring, E., and S. Kitasato. 1890. Über das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren (sic). Dtsch. Med. Wochenschr. 16:1113.
22. Mapara, M., R. Bargou, C. Zugck, H. Döhner, F. Ustaoglu, P. H. Krammer, and B. Dörken. 1993. APO-1-mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur. J. Immunol. 23:702.
23. Meyaard, L., S. A. Otto, R. R. Jonker, M. J. Mijnster, R. P. M. Keet, and F. Miedema. 1992. Programmed death of T cells in HIV infection. Science 257:217.
24. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215.
25. Sedgwick, J. D., and P. G. Holt. 1983. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 57:301.
26. Czerkinsky, C. C., L.-A. Nilsson, H. Nygren, O. Ouchterlony, and A. Tarkowski. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65:109.
27. Hasbold, J., and G. G. Klaus. 1990. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur. J. Immunol. 20:1685.
28. Benhamou, L. E., P. A. Cazenave, and P. Sarthou. 1990. Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 20:1405.
29. Hartley, S. B., M. P. Cooke, D. A. Fulcher, A. W. Harris, S. Cory, A. Basten, and C. C. Goodnow. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72:325.
30. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, R. J. Trent, and A. Basten. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334:676.
31. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji, A. Yachie, S. Yonehara, and N. Taniguchi. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149:3753.
32. Falk, M. H., B. C. Trauth, K. M. Debatin, C. Klas, C. D. Gregory, A. B. Rickinson, A. Calender, G. M. Lenoir, J. W. Ellwart, and P. H. Krammer. 1992. Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood 79:3300.
33. Leithäuser, F., J. Dhein, G. Mechtersheimer, K. Koretz, S. Brüderlein, C. Henne, A. Schmidt, K.-M. Debatin, P. H. Krammer, and P. Möller. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily in normal and neoplastic cells. Lab. Invest. 69:415.
34. Möller, P., C. Henne, F. Leithäuser, A. Eichelmann, A. Schmidt, S. Brüderlein, J. Dhein, and P. H. Krammer. 1993. Coregulation of the APO-1 antigen with inter cellular adhesion molecule-1 (CD54) in tonsillar B cells and ccordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphomas. Blood 81: 2067.
35. Holder, M. J., H. Wang, M. Casamayor, R. Armitage, M. Spriggs, W. C. Fanslow, I. C. M. MacLennan, C. D. Gregory, and J. Gordon. 1993. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of bcl-2 induction. Eur. J. Immunol. 23:2368.
36. Clark, E. A., and P. J. Lane. 1991. Regulation of human B-cell activation and adhesion. Annu. Rev. Immunol. 9:97.
37. Goodwin, R. G., M. R. Alderson, C. A. Smith, R. J. Armitage, T. van den Bos, R. Jerzy, T. W. Tough, M. A. Schoenborn, T. Davis-Smith, K. Hennen, B. Falk, D. Cosman, E. Baker, G. R. Sutherland, K. H. Grabstein, T. Farrah, J. G. Giri, and M. P. Beckmann. 1993. Molecular and biological characterization of a ligand for CD27 defines a family of cytokines with homology to tumor necrosis factor. Cell 73:447.
38. van Oers, M. H. J., S. T. Pals, L. M. Evers, C. E. van der Schoot, G. Koopman, J. M. G. Bonfrer, R. Q. Hintzen, A. E. G. K. von dem Borne, and R. A. W. van Lier. 1994. Expression and release of CD27 in human B cell malignancies. Blood 82:3430.
39. Perkins, D. L., R. M. Glaser, C. A. Mahon, J. Michaelson, and A. Marshak-Rothenstein. 1990. Evidence for an intrinsic B cell defect in lpr/lpr mice apparent in neonatal chimeras. J. Immunol. 145:549.